Testosterone Antibody (14P2C8)
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-78562
Key Product Details
Species Reactivity
Non-species specific
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, ELISA, Immunoprecipitation, Radioimmunoassay
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # 14P2C8
Concentration
1 mg/ml
Product Specifications
Immunogen
Testosterone-3-CMO-BSA
Reactivity Notes
Chemical
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Testosterone Antibody (14P2C8)
Application
Recommended Usage
ELISA
1:100 - 1:2000
Immunohistochemistry-Paraffin
1:10-1:500
Immunoprecipitation
1:10 - 1:500
Radioimmunoassay
1:100 - 1:2000
Formulation, Preparation, and Storage
Purification
Ion exchange chromatography
Formulation
0.01M potassium phosphate with 0.135M NaCl, 1mg/ml BSA, 2.5mM KCl
Preservative
0.05% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Testosterone
Testosterone is an important secreted androgen synthesized from cholesterol-derived pregnenolone. Circulating testosterone is predominantly bound to proteins, including specific sex hormone binding globulin (SHBG) and nonspecific proteins such as albumin. It is believed that bioavailable testosterone includes the free steroid and the albumin-bound form. Testosterone is the main androgen secreted by the Leydig cells of the testes and affects both primary and secondary sexual development.
Alternate Names
17b-Hydroxyandrost-4-ene-3-one, 17b-Testosterone
Additional Testosterone Products
Product Documents for Testosterone Antibody (14P2C8)
Product Specific Notices for Testosterone Antibody (14P2C8)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...